4.6 Article

The Bristol Sponge Microbiome Collection: A Unique Repository of Deep-Sea Microorganisms and Associated Natural Products

Journal

ANTIBIOTICS-BASEL
Volume 9, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/antibiotics9080509

Keywords

natural products; microbiology; antibiotics; extremophiles; bioprospecting; actinomycetes

Funding

  1. BBSRC [BB/T001968/1, BB/L01386X/1, BB/M025624/1]
  2. MRC GW4 BIOMED DTP [MR/N0137941/1]
  3. EPSRC Centre for Doctoral Training in Synthetic Biology [EP/L016494/1]
  4. Newton International Fellowship [NF171419]
  5. European Research Council via the ERC [278705, JC094]
  6. European Research Council (ERC) [278705] Funding Source: European Research Council (ERC)
  7. BBSRC [BB/M025624/1, BB/T001968/1, BB/L01386X/1] Funding Source: UKRI
  8. MRC [1952965] Funding Source: UKRI

Ask authors/readers for more resources

The deep ocean is the largest habitat for life on Earth, though the microorganisms that occupy this unique environmental niche remain largely unexplored. Due to the significant logistical and operational challenges associated with accessing the deep ocean, bioprospecting programmes that seek to generate novel products from marine organisms have, to date, focused predominantly on samples recovered from shallow seas. For this reason, the deep ocean remains a largely untapped resource of novel microbiological life and associated natural products. Here we report the establishment of the Bristol Sponge Microbiome Collection (BISECT), a unique repository of deep-sea microorganisms and associated metabolites isolated from the microbiota of marine sponges, recovered from previously unsurveyed regions of the mid Atlantic Ocean, at depths of 0.3-3 km. An integrated biodiscovery pipeline comprising molecular, genetic, bioinformatic and analytical tools is also described, which is being applied to interrogate this collection. The potential of this approach is illustrated using data reporting our initial efforts to identify antimicrobial natural product lead compounds. Prospects for the use of BISECT to address allied pharmaceutical needs, along with mechanisms of access to the collection are also discussed

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available